No abstract available
MeSH terms
-
Adrenal Cortex Hormones / adverse effects
-
Adrenal Cortex Hormones / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Antitubercular Agents / adverse effects
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Comorbidity
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
HIV Infections / complications
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Incidence
-
India / epidemiology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Purpura, Thrombocytopenic, Idiopathic / complications
-
Purpura, Thrombocytopenic, Idiopathic / drug therapy
-
Purpura, Thrombocytopenic, Idiopathic / epidemiology*
-
Retrospective Studies
-
Rifampin / adverse effects
-
Thrombocytopenia / chemically induced
-
Tuberculosis / complications
-
Tuberculosis / epidemiology*
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Adrenal Cortex Hormones
-
Antitubercular Agents
-
Immunosuppressive Agents
-
Vincristine
-
Asparaginase
-
Prednisone
-
Rifampin
-
Daunorubicin